Vemmou, E. Koromboki, et al. Acta Cardiol, 67 , pp. Krijthe, A. Kunst, E. Benjamin, G. Lip, O. Franco, A. Hofman, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from to Eur Heart J, 34 , pp.
Rev Esp Cardiol, 55 , pp. Cordero, V. Moreno-Arribas, V. Rev Esp Cardiol, 64 , pp. Formiga, X. Bosch, J. Med Clin Barc , , pp. Morillas, V. Pallares, J. Llisterri, C. Sanchis, T.
Rev Esp Cardiol, 63 , pp. Amo, I. Sainz, A. Guisado, J. Adriaensens, et al. Cardiocore, 47 , pp. Barrios, A. Escobar, M. De la Figuera. Rev Esp Cardiol, 65 , pp. Sala, J. Marrugat, A. Rev Esp Cardiol, 54 , pp. Merino Segovia, C. Segura Fragoso, C. Prevalence of auricular fibrillation in people over 65 years of age in a health area.
Aten Primaria, 28 , pp. Clua-Espuny, I. Lechuga-Duran, R. Bosch-Princep, A. Roso-Llorach, A. Panisello- Tafalla, J. Lucas-Noll, et al. Grau, R. Elosua, M. Sorribes, et al. Rev Clin Esp, , pp.
Alonso Martin, G. Lobos, P. Awamleh, et al. Rev Esp Cardiol, 67 , pp. Kannel, R. Abbott, D. Savage, P. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med, , pp. Piccini, B. Hammill, M. Sinner, P. Jensen, A. Hernandez, S. Heckbert, et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, Circ Cardiovasc Qual Outcomes, 5 , pp. Martinez, A. Katholing, C. Wallenhorst, S. Granziera, A. Cohen, S.
Increasing incidence of non-valvular atrial fibrillation in the UK from to Heart, , pp. Chugh, R. Havmoeller, K. Narayanan, D.
Singh, M. Roselli, A. Rodriguez, A. Rev Col Cardiol. Wattigney, G. Mensah, J. Increasing trends in hospitalization for atrial fibrillation in the United States, through implications for primary prevention. Friberg, P. Buch, H. Scharling, et al. Rising rates of hospital admissions for atrial fibrillation. Benjamin, D. Levy, S. Vaziri, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.
Kannel, R. Abbott, D. Savage, et al. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. Krahn, J. Manfreda, R. Tate, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. Kudaiberdieva, G. Lip, R. Mahajan, T. Potpara, J. Ramirez, M. Vos, F. Freedman, G. Boriani, T. Glotzer, J. Healey, P. Kirchhof, T. Management of atrial high-rate episodes detected by cardiac implanted electronic devices.
Nat Rev Cardiol, 14 , pp. Perino, J. Fan, M. Askari, P. Heidenreich, E. Keung, M. Raitt, J. Piccini, P. Practice variation in anticoagulation prescription and outcomesafter device-detected atrial fibrillation. Steinberg, H. Li, P. Thirty-second gold standard definitionof atrial fibrillation and its relationship with subsequent arrhythmia patterns: analysisof a large prospective device database.
Circ Arrhythm Electrophysiol;, 11 , pp. Camm, E. Simantirakis, A. Goette, G. Lip, P. Vardas, M. Calvert, G. Chlouverakis, H. Diener, P. Atrial high-rate episodes and Stroke prevention.. Europace, 19 , pp. Pollak, J. Simmons, A. Interian Jr.
Atapattu, A. Castellanos, R. Myerburg, R. Clinical utility of intraatrial pacemaker stored electrograms to diagnoseatrial fibrillation and flutter. Pacing Clin Electrophysiol, 24 , pp. Kaufman, C. Israel, G. Nair, L. Armaganijan, S. Divakaramenon, G. Mairesse, A. Brandes, E. Crystal, O. Costantini, R. Sandhu, R. Parkash, S. Connolly, S. Hohnloser, J. Positivepredictive value of device-detected atrial high-rate episodes at different rates anddurations: an analysis from ASSERT.
Heart Rhythm, 9 , pp. Benjamin, P. Muntner, A. Alonso, M. Bittencourt, C. Callaway, A. Carson, A. Chamberlain, A. Chang, S. Cheng, S. Das, F. Delling, L. Ferguson, M. Fornage, L. Jordan, S. Khan, B. Kissela, K. Knutson, T. Kwan, D. Lackland, T. Lewis, J. Lichtman, C. Longenecker, M. Loop, P. Lutsey, S. Martin, K. Matsushita, A. Moran, M.
Mussolino, M. Pandey, A. Perak, W. Rosamond, G. Roth, U. Sampson, G. Satou, E. Schroeder, S. Shah, N. Spartano, A. Stokes, D. Tirschwell, C. Tsao, M. Turakhia, L. VanWagner, J.
Wilkins, S. Wong, S. Heart disease and Stroke statistics - update: a report from the American Heart Association. Chugh, R. Havmoeller, K. Narayanan, D. Singh, M. Rienstra, E. Benjamin, GillumRF, Y. Kim, J. McAnulty Jr. Zheng, M. Forouzanfar, M. Naghavi, G. Mensah, M. Ezzati, C. Worldwide epidemiology of atrial fibrillation: a GlobalBurden of Disease Study. Colilla, A. Crow, W. Petkun, D. Singer, T. Simon, X.
Estimates of currentand future incidence and prevalence of atrial fibrillation in the US adult population. Am J Cardiol, , pp. Krijthe, A. Kunst, E.
Benjamin, G. Lip, O. Franco, A. Hofman, J. Witteman, B. Stricker, J. Projections on the number of individuals with atrial fibrillationin the European Union, from to Eur Heart, 34 , pp. Dewland, J. Olgin, E. Vittinghoff, G. Incident atrial fibrillation amongAsians, Hispanics, blacks, and whites..
Circulation;, , pp. Staerk, J. Sherer, D. Ko, E. Benjamin, R. Atrial fibrillation: epidemiology,pathophysiology, and clinical outcomes. Circ Res;, , pp. Alonso, S. Agarwal, E. Soliman, M. Ambrose, A. Chamberlain, R.
Prineas, A. Am Heart, , pp. Chao, C. Liu, T. Tuan, T. Hsieh, G. Lip, S. Lifetimerisks, projected numbers, and adverse outcomes in Asian patients with atrialfibrillation: a report from the Taiwan Nationwide AF Cohort Study. Chest, , pp.
Guo, Y. Tian, H. Wang, Q. Si, Y. Wang, G. Prevalence, incidence, and lifetimerisk of atrial fibrillation in China: new insights into the global burden of atrialfibrillation. Ko, F. Rahman, R. Schnabel, X. Yin, E. Benjamin, I. Atrial fibrillationin women: epidemiology, pathophysiology, presentation, and prognosis..
Nat Rev Cardiol, 13 , pp. Mou, F. Norby, L. Chen, W. Lewis, L. Loehr, E. Soliman, A. Circ Arrhythm Electrophysiol, 11 , pp. Boriani, I. Savelieva, G. Dan, J. Deharo, C. Ferro, C. Israel, D. Lane, La MannaG, J. Morton, A. Mitjans, M. Vos, M. Turakhia, G. Chronic kidney disease inpatients with cardiac rhythm disturbances or implantable electrical devices: clinicalsignificance and implications for decision making - a position paper of the EuropeanHeart Rhythm Association endorsed by the Heart Rhythm Society and the AsiaPacific Heart Rhythm Society.
Europace, 17 , pp. Aune, T. Feng, S. Schlesinger, I. Janszky, T. Norat, E. Diabetes mellitus,blood glucose and the risk of atrial fibrillation: a systematic review and metaanalysisof cohort studies.
J Diabetes Complications, 32 , pp. Cadby, N. McArdle, T. Briffa, D. Hillman, L. Simpson, M. Knuiman, J. Severity of OSA is an independent predictor of incident atrial fibrillation hospitalizationin a large sleep-clinic cohort.
Hobbelt, J. Siland, B. Geelhoed, P. Van Der Harst, H. Hillege, I. Van Gelder, M. Clinical, biomarker, and genetic predictors of specific types of atrialfibrillation in a community-based cohort: data of the PREVEND study. Nalliah, P. Sanders, J. The impact of diet and lifestyle on atrial fibrillation. Curr Cardiol Rep, 20 , pp.
Lip, A. Coca, T. Kahan, G. Boriani, A. Manolis, M. Olsen, A. Oto, PotparaTS, J. Steffel, F. Marin, M. Tzou, C. Chiang, B. Williams, Reviewers, G. Dan, B. Gorenek, L.
Fauchier, I. Savelieva, R. Hatala, I. Brguljan-Hitij, S. Erdine, D. Lovic, Y. Salinas-Arce, M. Gallagher, J. Hendriks, A. Elliott, C. Wong, G. Rangnekar, M. Middeldorp, R. Mahajan, D. Lau, P. Alcohol and incident atrial fibrillation - a systematicreview and meta-analysis. Int J Cardiol, , pp. Ricci, F. Gervasi, M. Finalmente la letra C se refiere a corregir los factores de riesgo cardiovasculares y las comorbilidades en forma conjunta. SAC Joven. Objetivo 25x Stent — Save a Life.
Ultimos consensos agregados.
0コメント